Sleep Disorders in Neuromuscular Diseases

Neurologic Clinics

Volumn 30, Issue 4, 2012, Pages 1359-1387

  Bhat, Sushanth ^a   Gupta, Divya ^a   Chokroverty, Sudhansu ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Breathing in amyotrophic lateral sclerosis; Obstructive sleep apnea; Polysomnography in neuromuscular diseases; Sleep complaints in myopathies; Sleep dysfunction in myotonic dystrophy; Sleep dysfunction in neuromuscular diseases; Sleep disordered breathing in neuromuscular diseases

Indexed keywords

AMPHETAMINE DERIVATIVE; ARMODAFINIL; GABAPENTIN; METHYLPHENIDATE; MODAFINIL; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTERIAL GAS; BLOOD GAS ANALYSIS; CAPNOGRAPHY; DAYTIME SOMNOLENCE; DIAGNOSTIC TEST; DUCHENNE MUSCULAR DYSTROPHY; EXCESSIVE DAYTIME SLEEPINESS; GOLD STANDARD; GUILLAIN BARRE SYNDROME; HUMAN; HYPOVENTILATION; LIMB GIRDLE MUSCULAR DYSTROPHY; LUNG FUNCTION TEST; MYASTHENIA GRAVIS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NOCTURNAL HYPOVENTILATION; NOCTURNAL RESPIRATORY FAILURE; NONREM SLEEP; OXYGEN THERAPY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PULSE OXIMETRY; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SNIFF FUNCTION TEST; SPINAL MUSCULAR ATROPHY; SYMPTOMATOLOGY; TRACHEOSTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; WAKEFULNESS;

HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MUSCULAR DISEASES; NEUROMUSCULAR DISEASES; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84867910122     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.08.010     Document Type: Review

References (113)

1. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991, 14(6):540-545.
2. Chervin R.D., Aldrich M.S., Pickett R., et al. Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test. J Psychosom Res 1997, 42(2):145-155.
3. Benbadis S.R., Mascha E., Perry M.C., et al. Association between the Epworth Sleepiness Scale and the Multiple Sleep Latency Test in a clinical population. Ann Intern Med 1999, 130(4 Pt 1):289-292.
4. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993, 103(1):30-36.
5. Furuta H., Kaneda R., Kosaka K., et al. Epworth Sleepiness Scale and sleep studies in patients with obstructive sleep apnea syndrome. Psychiatry Clin Neurosci 1999, 53:301-302.
6. Steier J., Jolley C.J., Seymour J., et al. Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis. Eur Respir J 2011, 37(2):400-405.
7. Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care 2006, 51(9):1016-1021.
8. Chokroverty S. Sleep and breathing in neuromuscular disorders. Handb Clin Neurol 2011, 99:1087-1108.
9. Mangera Z., Panesar G., Makker H. Practical approach to management of respiratory complications in neurological disorders. Int J Gen Med 2012, 5:255-263.
10. Culebras A. Sleep and neuromuscular disorders. Neurol Clin 2005, 23(4):1209-1223.
11. Iber C., Ancoli-Israel S., Chesson A.L., et al. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications 2007, American Academy of Sleep Medicine, Westchester (IL).
12. Mortimore I.L., Bennett S.P., Douglas N.J. Tongue protrusion strength and fatiguability: relationship to apnoea/hypopnoea index and age. J Sleep Res 2000, 9(4):389-393.
13. Eckert D.J., Sabiosky J.P., Jordan A.S., et al. Upper airway myopathy is not important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med 2007, 3(6):570-573.
14. Dhand U.K., Dhand R. Sleep disorders in neuromuscular diseases. Curr Opin Pulm Med 2006, 12(6):402-408.
15. Hutchinson D., Whyte K. Neuromuscular disease and respiratory failure. Pract Neurol 2008, 8(4):229-237.
16. Hukins C.A., Hillman D.R. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000, 161(1):166-170.
17. Frankenstein L., Nelles M., Meyer F.J., et al. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. Eur J Cardiovasc Prev Rehabil 2009, 16:424.
18. Vilaró J., Ramirez-Sarmiento A., Martínez-Llorens J.M., et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 2010, 104:1896.
19. Moore A.J., Soler R.S., Cetti E.J., et al. Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD. Respir Med 2010, 104:1319.
20. Fiz J.A., Carreres A., Rosell A., et al. Measurement of maximal expiratory pressure: effect of holding the lips. Thorax 1992, 47:961.
21. Ragette R., Mellies U., Schwake C., et al. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002, 57(8):724-728.
22. Mellies U., Ragette R., Schwake C., et al. Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord 2003, 13(2):123-128.
23. Lechtzin N., Wiener C.M., Shade D.M., et al. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002, 121(2):436-442.
24. Varrato J., Siderowf A., Damiano P., et al. Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology 2001, 57(2):357-359.
25. Bégin P., Mathieu J., Almirall J., et al. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 1997, 156(1):133-139.
26. Kumar S.P., Sword D., Petty R.K., et al. Assessment of sleep studies in myotonic dystrophy. Chron Respir Dis 2007, 4(1):15-18.
27. Winhammar J.M., Joffe D., Simmul R., et al. Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests. Intern Med J 2006, 36(7):419-422.
28. Heritier F., Rahm F., Pasche P., et al. Sniff nasal inspiratory pressure; A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med 1994, 150(6):1678-1683.
29. Stefanutti D., Benoist M.R., Sceinman P., et al. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 2000, 162(4):1507-1511.
30. Morgan R.K., McNally S., Alexander M., et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005, 171(3):269-274.
31. Lyall R.A., Donaldson N., Polkey M.I., et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001, 124(Pt 10):2000-2013.
32. Carratù P., Cassano A., Gadaleta F., et al. Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results. Amyotroph Lateral Scler 2001, 12(6):458-463.
33. Anderson V.B., McKenzie J.A., Seton C., et al. Sniff nasal inspiratory pressure and sleep disordered breathing in childhood neuromuscular disorders. Neuromuscul Disord 2012, 22(6):528-533.
34. Steier J., Kaul S., Seymour J., et al. The value of multiple tests of respiratory muscle strength. Thorax 2007, 62:975-980.
35. Hart N., Plokey M.I., Sharshar T., et al. Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry 2003, 74:1685-1687.
36. de Carvalho M., Costa J., Pinto S., et al. Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation. Amyotroph Lateral Scler 2009, 10(3):154-161.
37. Netzer N., Eliasson A.H., Netzer C., et al. Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest 2001, 120(2):625-633.
38. Nardi J., Prigent H., Adala A., et al. Nocturnal oximetry and transcutaneous carbon dioxide in home-ventilated neuromuscular patients. Respir Care 2012, 57(9):1425-1430.
39. Kim S., Park K.S., Nam H., et al. Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS. PLoS One 2011, 6(3):e17893.
40. Collop N., Anderson M., Boehlecke B., et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007, 3(7):737-747.
41. Smith I.E., King M.A., Shneerson J.M. Choosing a negative pressure ventilation pump: are there any important differences?. Eur Respir J 1995, 8:1792-1795.
42. Shneerson J.M., Simonds A.K. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002, 20(2):480-487.
43. Kleopa K.A., Sherman M., Neal B., et al. BIPAP improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999, 164(1):82-88.
44. Aboussouan L.S., Khan S.U., Meeker D.P., et al. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997, 127:450-453.
45. Lo Coco D., Marchese S., Pesco M.C., et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006, 67(5):761-765.
46. Lyall R.A., Donaldson N., Fleming T., et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001, 57(1):153-156.
47. Newsom-Davis I.C., Lyall R.A., Leigh P.N., et al. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry 2001, 71:482-487.
48. Boitano L.J., Jordan T., Benditt J.O. Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 2001, 56(3):413-414.
49. Mustfa N., Walsh E., Bryant V., et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006, 66(8):1211-1217.
50. Consensus conference report: clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation. Chest 1999, 116(2):521-534.
51. Miller R.G., Jackson C.E., Kasarskis E.J., et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73(15):1218-1226.
52. Jackson C.E., Rosenfeld J., Moore D.H., et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 2001, 191(1-2):75-78.
53. Berry R.B., Chediak A., Brown L.K., et al. NPPV titration task force of the American Academy of Sleep Medicine. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med 2010, 6(5):491-509.
54. Gay P.C., Edmonds L.C. Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction. Mayo Clin Proc 1995, 70(4):327-330.
55. Scherer K., Bedlack R.S. Diaphragm pacing in amyotrophic lateral sclerosis: a literature review. Muscle Nerve 2012, 46(1):1-8.
56. Amirjani N., Kiernan M.C., McKenzie D.K., et al. Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?. Amyotroph Lateral Scler 2012, 13(6):521-527.
57. Onders R.P., Elmo M., Khansarinia S., et al. Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 2009, 23(7):1433-1440.
58. Lal R., Ellenbogen A., Chen D., et al. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome. Clin Neuropharmacol 2012, 35(4):165-173.
59. Lo Coco D., Mattaliano P., Spataro R., et al. Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011, 82(8):839-842.
60. Barthlen G.M., Lange D.J. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol 2000, 7(3):299-302.
61. Takekawa H., Kubo J., Miyamoto T., et al. Amyotrophic lateral sclerosis associated with insomnia and the aggravation of sleep-disordered breathing. Psychiatry Clin Neurosci 2001, 55(3):263-264.
62. Kimura K., Tachibana N., Kimura J., et al. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci 1999, 164(1):37-43.
63. Atalaia A., De Carvalho M., Evangelista T., et al. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler 2007, 8(2):101-105.
64. David W.S., Bundlie S.R., Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci 1997, 152(Suppl 1):S29-S35.
65. Carratù P., Spicuzza L., Cassano A., et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency. Orphanet J Rare Dis 2009, 4:10.
66. Testa M.B., Pavone M., Bertini E., et al. Sleep-disordered breathing in spinal muscular atrophy types 1 and 2. Am J Phys Med Rehabil 2005, 84(9):666-670.
67. Mellies U., Dohna-Schwake C., Stehling F., et al. Sleep disordered breathing in spinal muscular atrophy. Neuromuscul Disord 2004, 14(12):797-803.
68. Petrone A., Pavone M., Testa M.B., et al. Noninvasive ventilation in children with spinal muscular atrophy types 1 and 2. Am J Phys Med Rehabil 2007, 86(3):216-221.
69. Lemoine T.J., Swoboda K.J., Bratton S.L., et al. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?. Pediatr Crit Care Med 2012, 13(3):e161-e165.
70. Trojan D.A., Cashman N.R. Post-poliomyelitis syndrome. Muscle Nerve 2005, 31:6-19.
71. van Kralingen K.W., Ivanyi B., van Keimpema A.R., et al. Sleep complaints in postpolio syndrome. Arch Phys Med Rehabil 1996, 77(6):609-611.
72. Steljes D.G., Kryger M.H., Kirk B.W., et al. Sleep in postpolio syndrome. Chest 1990, 98(1):133-140.
73. Silva T.M., Moreira G.A., Quadros A.A., et al. Analysis of sleep characteristics in post-polio syndrome patients. Arq Neuropsiquiatr 2010, 68(4):535-540.
74. Araujo M.A., Silva T.M., Moreira G.A., et al. Sleep disorders frequency in post-polio syndrome patients caused by periodic limb movements. Arq Neuropsiquiatr 2010, 68(1):35-38.
75. Marin L.F., Carvalho L.B., Prado L.B., et al. Restless legs syndrome in post-polio syndrome: a series of 10 patients with demographic, clinical and laboratorial findings. Parkinsonism Relat Disord 2011, 17(7):563-564.
76. Nabatame S., Taniike M., Sakai N., et al. Sleep disordered breathing in childhood-onset acid maltase deficiency. Brain Dev 2009, 31(3):234-239.
77. Smith P.E., Edwards R.H., Calverley P.M. Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy. Chest 1989, 96(6):1346-1351.
78. Smith P.E., Calverley P.M., Edwards R.H. Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988, 137(4):884-888.
79. Raphael J., Chevret S., Chastang C., et al. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet 1994, 343(8913):1600-1604.
80. Ishikawa Y., Ishikawa Y., Minami R. Rinsho Shinkeigaku 1993, 33(8):856-861. [in Japanese].
81. Vianello A., Bevilacqua M., Salvador V., et al. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest 1994, 105(2):445-448.
82. Kelly E., Farrell M.A., McElvaney N.G. Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care 2008, 53(11):1490-1494.
83. Polat M., Tosun A., Ay Y., et al. Central core disease: atypical case with respiratory insufficiency in an intensive care unit. J Child Neurol 2006, 21(2):173-174.
84. Pinard J.M., Azabou E., Essid N., et al. Sleep-disordered breathing in children with congenital muscular dystrophies. Eur J Paediatr Neurol 2012, 10.1016/j.ejpn.2012.02.009.
85. Barbe F., Quera-Salva M.A., de Lattre J., et al. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest 1996, 110(5):1179-1183.
86. Quera Salva M.A., Blumen M., Jacquette A., et al. Sleep disorders in childhood-onset myotonic dystrophy type 1. Neuromuscul Disord 2006, 16(9-10):564-570.
87. Pincherle A., Patruno V., Raimondi P., et al. Sleep breathing disorders in 40 Italian patients with Myotonic dystrophy type 1. Neuromuscul Disord 2012, 22(3):219-224.
88. Romigi A., Izzi F., Pisani V., et al. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol 2011, 18(9):1139-1145.
89. Yu H., Laberge L., Jaussent I., et al. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep 2011, 34(2):165-170.
90. Laberge L., Bégin P., Montplaisir J., et al. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004, 13(1):95-100.
91. Ciafaloni E., Mignot E., Sansone V., et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008, 70(3):226-230.
92. Iwata T., Suzuki N., Mizuno H., et al. Rinsho Shinkeigaku 2009, 49(7):437-439. [in Japanese].
93. Martínez-Rodríguez J.E., Lin L., Iranzo A., et al. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep 2003, 26(3):287-290.
94. Giubilei F., Antonini G., Bastianello S., et al. Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 1999, 164(1):60-63.
95. Tieleman A.A., Knoop H., van de Logt A.E., et al. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. J Neurol Neurosurg Psychiatry 2010, 81(9):963-967.
96. Bhat S, Sander HW, Grewal RP, et al. Sleep disordered breathing and other sleep dysfunction in myotonic dystrophy type 2. Sleep Med, in press.
97. Chokroverty S., Bhat S., Rosen D., et al. REM behavior disorder in myotonic dystrophy type 2. Neurology 2012, 78(24):2004.
98. Nicolle M.W., Rask S., Koopman W.J., et al. Sleep apnea in patients with myasthenia gravis. Neurology 2006, 67(1):140-142.
99. Shintani S., Shiozawa Z., Shindo K., et al. Rinsho Shinkeigaku 1989, 29(5):547-553. [in Japanese].
100. Stepansky R., Weber G., Zeitlhofer J. Wien Med Wochenschr 1996, 146(9-10):209-210. [in German].
101. Gajdos P., Quera Salva M.A. Rev Neurol (Paris) 2001, 157(11 Pt 2):S145-S147. [in French].
102. Manni R., Piccolo G., Sartori I., et al. Breathing during sleep in myasthenia gravis. Ital J Neurol Sci 1995, 16(9):589-594.
103. Prudlo J., Koenig J., Ermert S., et al. Sleep disordered breathing in medically stable patients with myasthenia gravis. Eur J Neurol 2007, 14(3):321-326.
104. Karkare K., Sinha S., Taly A.B., et al. Prevalence and profile of sleep disturbances in Guillain-Barré Syndrome: a prospective questionnaire-based study during 10 days of hospitalization. Acta Neurol Scand 2012, 10.1111/j.1600-0404.2012.01688.
105. Cochen V., Arnulf I., Demeret S., et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain 2005, 128(Pt 11):2535-2545.
106. Nishino S., Kanbayashi T., Fujiki N., et al. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology 2003, 61(6):823-825.
107. Koeppen S., Kraywinkel K., Wessendorf T.E., et al. Long-term outcome of Guillain-Barré syndrome. Neurocrit Care 2006, 5(3):235-242.
108. Dziewas R., Waldmann N., Böntert M., et al. Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study. J Neurol Neurosurg Psychiatry 2008, 7:829-831.
109. Dematteis M., Pépin J.L., Jeanmart M., et al. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet 2001, 357(9252):267-272.
110. Boentert M., Dziewas R., Heidbreder A., et al. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol 2010, 257(4):646-652.
111. Barraclough A., Triplett J., Tuch P. Brachial neuritis with phrenic nerve involvement. J Clin Neurosci 2012, 19(9):1301-1302.
112. Chan C.K., Mohsenin V., Loke J., et al. Diaphragmatic dysfunction in siblings with HMSN. Chest 1987, 91:567-570.
113. Ostrowska M., de Carvalho M. Prognosis of phrenic nerve injury following thoracic interventions: four new cases and a review. Clin Neurol Neurosurg 2012, 114(3):199-204.